|
Video: What is a Stock Split?
|
|
Alexza Pharmaceuticals is a pharmaceutical company focused on the research, development and commercialization of proprietary products for the acute treatment of central nervous system conditions. ADASUVE® (Staccato loxapine), and all of Co.'s product candidates are based on the Staccato® system, Co.'s proprietary technology. The Staccato system vaporizes excipient-free drugs to form a condensation aerosol. ADASUVE has been developed for the treatment of agitation associated with schizophrenia or bipolar disorder. Co.'s product candidate in development, AZ-002 (Staccato alprazolam), is being developed for the management of patients with acute repetitive seizures. According to our ALXA split history records, ALXA has had 1 split. | |
|
ALXA (ALXA) has 1 split in our ALXA split history database. The split for ALXA took place on June 13, 2012. This was a 1 for 10 reverse split, meaning for each 10 shares of ALXA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as ALXA conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ALXA split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ALXA shares, starting with a $10,000 purchase of ALXA, presented on a split-history-adjusted basis factoring in the complete ALXA split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/11/2014 |
|
End date: |
03/20/2017 |
|
Start price/share: |
$1.45 |
|
End price/share: |
$0.94 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-35.17% |
|
Average Annual Total Return: |
-17.37% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$6,483.37 |
|
Years: |
2.27 |
|
|
|
Date |
Ratio |
06/13/2012 | 1 for 10 |
|
|